Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19
- PMID: 32614442
- PMCID: PMC7333173
- DOI: 10.1001/jamaoto.2020.1379
Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19
Abstract
Importance: An altered sense of smell and taste has been reported to be associated with coronavirus disease 2019 (COVID-19). To understand the evolution of these symptoms during the course of the disease is important to identify patients with persistent loss of smell or taste and estimate the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the burden of olfactory and gustative dysfunctions.
Objective: To evaluate the evolution of the loss of sense of smell and taste in a case series of mildly symptomatic patients with SARS-CoV-2 infection.
Design, setting, and participants: This cross-sectional survey-based study included 202 mildly symptomatic adults (≥18 years) consecutively assessed at Treviso Regional Hospital, Italy, between March 19 and March 22, 2020, who tested positive for SARS-CoV-2 RNA by polymerase chain reaction on nasopharyngeal and throat swabs.
Main outcomes and measures: Prevalence of altered sense of smell and taste at follow-up and their variation from baseline.
Results: Of 202 patients completing the survey at baseline, 187 (92.6%) also completed the follow-up survey (103 [55.1%] women; median age, 56 years). The evaluation of the evolution of altered sense of smell or taste in the 113 patients reporting sudden onset of these symptoms at baseline showed that 55 patients (48.7%; 95% CI, 39.2-58.3) reported complete resolution of smell or taste impairment, 46 (40.7%; 95% CI, 31.6-50.4) reported an improvement in the severity, and only 12 (10.6%; 95% CI, 5.6-17.8) reported the symptom was unchanged or worse. Persistent loss of smell or taste was not associated with persistent SARS-CoV-2 infection.
Conclusions and relevance: At 4 weeks from the onset, 89% of the SARS-CoV-2-positive mildly symptomatic patients who had had a sudden onset of altered sense of smell or taste experienced a complete resolution or improvement of these symptoms. Persistent loss of smell or taste was not associated with persistent SARS-CoV-2 infection.
Conflict of interest statement
Comment in
-
Treatment Recommendations for Persistent Smell and Taste Dysfunction Following COVID-19-The Coming Deluge.JAMA Otolaryngol Head Neck Surg. 2020 Aug 1;146(8):733. doi: 10.1001/jamaoto.2020.1378. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32614399 Free PMC article. No abstract available.
-
Understanding COVID-19-Related Olfactory Dysfunction.JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):109. doi: 10.1001/jamaoto.2020.4269. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33211116 No abstract available.
Similar articles
-
Evaluating long-term smell or taste dysfunction in mildly symptomatic COVID-19 patients: a 3-year follow-up study.Eur Arch Otorhinolaryngol. 2023 Dec;280(12):5625-5630. doi: 10.1007/s00405-023-08227-y. Epub 2023 Sep 16. Eur Arch Otorhinolaryngol. 2023. PMID: 37715807
-
Evolution of olfactory and gustatory dysfunctions in COVID-19 patients in India.Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2875-2881. doi: 10.1007/s00405-020-06563-x. Epub 2021 Jan 3. Eur Arch Otorhinolaryngol. 2021. PMID: 33392762 Free PMC article.
-
New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects.Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2637-2640. doi: 10.1007/s00405-020-06066-9. Epub 2020 May 24. Eur Arch Otorhinolaryngol. 2020. PMID: 32449021 Free PMC article.
-
A review of smell and taste dysfunction in COVID-19 patients.Med J Malaysia. 2020 Sep;75(5):574-581. Med J Malaysia. 2020. PMID: 32918429 Review.
-
[Taste and smell loss in patients with COVID-19].Ugeskr Laeger. 2020 Aug 31;182(36):V06200442. Ugeskr Laeger. 2020. PMID: 33000727 Review. Danish.
Cited by
-
Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review.Int Arch Otorhinolaryngol. 2024 May 25;28(4):e728-e743. doi: 10.1055/s-0044-1786046. eCollection 2024 Oct. Int Arch Otorhinolaryngol. 2024. PMID: 39464360 Free PMC article. Review.
-
Exploring cognitive impairments and the efficacy of phosphatidylcholine and computer-assisted cognitive training in post-acute COVID-19 and post-acute COVID-19 Vaccination Syndrome.Front Neurol. 2024 Sep 3;15:1419134. doi: 10.3389/fneur.2024.1419134. eCollection 2024. Front Neurol. 2024. PMID: 39291099 Free PMC article.
-
Chemosensory assessment and impact on quality of life in neurosensorial cluster of the post COVID 19 syndrome.Sci Rep. 2024 Sep 9;14(1):20951. doi: 10.1038/s41598-024-71475-3. Sci Rep. 2024. PMID: 39251830 Free PMC article.
-
Recovery of Smell and Taste in Patients With Persistent COVID-19-Related Hyposmia and Dysgeusia by Targeting Inflammation and Endothelial Dysfunction.Cureus. 2024 Feb 26;16(2):e54925. doi: 10.7759/cureus.54925. eCollection 2024 Feb. Cureus. 2024. PMID: 38544584 Free PMC article.
-
Persistent Olfactory and Taste Dysfunction after COVID-19.Life (Basel). 2024 Feb 28;14(3):317. doi: 10.3390/life14030317. Life (Basel). 2024. PMID: 38541643 Free PMC article.
References
-
- Coronavirus Update (Live) 510,528 Cases and 23,028 Deaths from COVID-19 Virus Outbreak—Worldometer. Accessed April 20, 2020. https://www.worldometers.info/coronavirus/
-
- Sungnak W, Huang N, Bécavin C, Berg M, Network HLB SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways. ArXiv200306122 Q-Bio. March 2020. Accessed April 6, 2020. https://arxiv.org/abs/2003.06122
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
